Looking to publish in JACC Basic to Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJACC: Basic to Translational Science is an open access specialist journal in the JACC family that serves as a forum for translational cardiovascular medicine and aims to accelerate the translation of scientific discoveries into therapies that improve outcomes for patients with or at risk for cardiovascular disease. Areas of interest include pre-clinical research, clinical trials, personalized medicine, novel drugs, devices and biologics, proteomics, genomics and metabolomics, and early phase clinical trial methodology.
Looking to publish in JACC Basic to Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
JACC Basic to Translational Science accepts the following article types. Click on an article type to view submission instructions.
Original Research Paper
State-Of-The-Art Papers
Leading Edge Translational Research
Leading Edge Translational Science
Letters To The Editor
Recent Publications
The Role of Cardiac Fibrosis and Fibroblast Activation in Amyloid Light Chain (AL) Amyloidosis
Shingo Narita, John Isaiah Jimenez, Nixuan Cai, Hiroki Kitakata, Sharmila Dorbala, Y. Joseph Woo, Kevin M. Alexander, Ronglih Liao
An Estrogen–IL-33 Circuit in Aortic Fibroblasts Underlies Sex Differences in Tregs in Abdominal Aortic Aneurysm
Wangling Hu, Jingyong Li, Luna Zhai, Zhuo Chen, Linwei Ye, Ni Xia, Tingting Tang, Shaofang Nie, Min Zhang, Jiao Jiao, Bingjie Lv, Fen Yang, Yuzhi Lu, Lingfeng Zha, Muyang Gu, Xiajun Hu, Shuang Wen, Dan Li, Desheng Hu, Weimin Wang, Chen Chen, Qing K. Wang, Zhilei Shan, Yong Ji, Xiang Cheng
Monocyte Transcriptional Reprogramming Explains Refractory In-Stent Restenosis
Joseph Bednarek, Juan Ibla, Edward B. Thorp
Rates of Lipoprotein(a) Oxidation Accelerate at Elevated Levels and Attenuate With Atorvastatin Active Metabolites Compared With Other Statins
Samuel C.R. Sherratt, Peter Libby, Deepak L. Bhatt, R. Preston Mason
Frequently asked questions
How long does it take to publish?
Leading Edge Translational Research and Leading Edge Translational Science submissions are reviewed for interest within seven days of submission. Expedited review requests receive a decision on suitability within 2 days and an initial decision within 14 days.
Reformat to JACC Basic to Translational Science using Livewrite PremiumIs a cover letter required?
A cover letter is required. It must state that the paper is not under consideration elsewhere, that its contents have not been previously published, that all authors have read and approved the manuscript, and disclose any potential conflicts of interest or state that none exist. The corresponding author must be specified. If there are more than 4 authors, each author's contribution must be substantiated in the cover letter. Authors requesting expedited review must include the request and rationale in the cover letter.
Reformat to JACC Basic to Translational Science using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 4750 for full length articles and USD 1900 for Short Communications (Research Letter), excluding taxes.
Reformat to JACC Basic to Translational Science using Livewrite Premium